Cue Biopharma Inc Est. EPS Q / Q
Mi az Cue Biopharma Inc Est. EPS Q / Q?
A Est. EPS Q / Q az Cue Biopharma Inc - 36.00%
Mi a Est. EPS Q / Q meghatározása?
A várható EPS negyedévenkénti növekedési üteme évről évre meghaladja a vállalat EPS-jének becsült növekedését a következő negyedévben az előző negyedévhez képest.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q a Health Care szektor a NASDAQ-on cégekben a Cue Biopharma Inc -hoz képest
Mit csinál Cue Biopharma Inc?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
est. eps q / q -hoz hasonló cégek Cue Biopharma Inc
- Moog nak Est. EPS Q / Q 35.51% van
- Byline Bancorp Inc nak Est. EPS Q / Q 35.56% van
- LIC Housing Finance nak Est. EPS Q / Q 35.56% van
- Enservco Corp nak Est. EPS Q / Q 35.71% van
- Chargepoint nak Est. EPS Q / Q 35.71% van
- ZTO Express (Cayman) Inc nak Est. EPS Q / Q 35.71% van
- Cue Biopharma Inc nak Est. EPS Q / Q 36.00% van
- Varun Beverages nak Est. EPS Q / Q 36.11% van
- RB Global Inc nak Est. EPS Q / Q 36.11% van
- Airbus SE nak Est. EPS Q / Q 36.21% van
- AIA Engineering nak Est. EPS Q / Q 36.25% van
- West Fraser Timber Co nak Est. EPS Q / Q 36.30% van
- Avis Budget Inc nak Est. EPS Q / Q 36.31% van